TY - JOUR
AU - ONTARGET Investigators
BT - Lancet
CN - Y
DA - -34748084820
LA - eng
LB - NMHjournal
M1 - 9638
PY - 2008
SP - 547
EP - 53.
T2 - Lancet
TI - Renal outcomes with telmisartan, ramipril, or both in people at high vascular risk: results from a multicenter, randomised, double-blind, controlled trial
VL - 372
ER -